Citius Oncology Announces Positive Developments with LYMPHIR™ Launch amidst Strong Market Adoption and Clinical Expansion Citius Oncology has reported a successful initial launch of LYMPHIR™, showing strong uptake in cancer centers and promising clinical studies supporting its use for CTCL treatment.

Citius Oncology Announces Positive Developments with LYMPHIR™ Launch amidst Strong Market Adoption and Clinical Expansion #USA #Cranford #CTCL #Citius_Oncology #LYMPHIR™

Citius Oncology's Encouraging Phase 1 Study Results for LYMPHIR and Pembrolizumab in Gynecologic Cancer Citius Oncology announced positive results from a Phase 1 trial of LYMPHIR used with pembrolizumab for treating difficult gynecologic cancers. These findings show promise for future therapies.

Citius Oncology's Encouraging Phase 1 Study Results for LYMPHIR and Pembrolizumab in Gynecologic Cancer #USA #Cranford #LYMPHIR #Citius_Oncology #Pembrolizumab

Citius Oncology Unveils Phase 1 Results for LYMPHIR™ Prior to CAR-T Therapy in High-Risk DLBCL Patients Citius Oncology has announced promising Phase 1 data highlighting the efficacy of LYMPHIR™ in patients with high-risk diffuse large B-cell lymphoma prior to CAR-T therapy.

Citius Oncology Unveils Phase 1 Results for LYMPHIR™ Prior to CAR-T Therapy in High-Risk DLBCL Patients #United_States #Cranford #CAR-T_therapy #LYMPHIR #Citius_Oncology

Chuzhao Adventure Toy Camera
#ChuzhaoAdventure #toycamera #digital #Cranford #Chuzhao

Chuzhao Adventure Toy Camera
#ChuzhaoAdventure #toycamera #digital #Cranford #Chuzhao

Citius Pharmaceuticals Grabs $3.8 Million from New Jersey's Economic Development Initiative Citius Pharmaceuticals has successfully obtained $3.8 million in non-dilutive capital from New Jersey's Economic Development Program, reinforcing its financial strength.

Citius Pharmaceuticals Grabs $3.8 Million from New Jersey's Economic Development Initiative #United_States #New_Jersey #Cranford #Citius_Pharmaceuticals #NOL_Program

Citius Pharmaceuticals Reports First Revenue from LYMPHIR Launch: A New Conquest in Oncology Citius Pharmaceuticals marks a significant milestone by announcing its first revenue from the newly launched LYMPHIR. This development points to a successful foothold in oncology, aiming to bring hope to patients.

Citius Pharmaceuticals Reports First Revenue from LYMPHIR Launch: A New Conquest in Oncology #United_States #Cranford #oncology #Citius_Pharmaceuticals #LYMPHIR

Citius Oncology Achieves First Revenue Milestone with LYMPHIR™ Launch Citius Oncology, Inc. made headlines as they reported their inaugural revenue stemming from the successful launch of their groundbreaking treatment, LYMPHIR™. This pivotal moment underscores the company's evolution into a commercial oncology entity.

Citius Oncology Achieves First Revenue Milestone with LYMPHIR™ Launch #United_States #Cranford #oncology #LYMPHIR #Citius_Oncology

Citius Oncology Partners with Uniphar to Distribute LYMPHIR™ in Europe Citius Oncology has announced a notable agreement with Uniphar to boost the distribution of LYMPHIR™ across Europe, enhancing access for patients.

Citius Oncology Partners with Uniphar to Distribute LYMPHIR™ in Europe #United_States #Cranford #LYMPHIR #Citius_Oncology #Uniphar

bsky.app/profile/did:...

#HANIF #KUREISHI
allgraph.ro/advanced-sea...
#CRANFORD #NOVEL
multi-search-tag-explorer.headlines-world.com/advanced-sea...
#BUHLEBEZWE #SIWANI
multi-search-tag-explorer.aepiot.ro/advanced-sea...
aepiot.ro

Snowy holidays in Cranford

#StunDay #NewJersey #Cranford #cold #photography #outdoor #EastCoastKin #winter #beautiful #photographersofbluesky #trainline #holidays

Citius Pharmaceuticals Unveils 2025 Financial Results and Strategic 2026 Goals Citius Pharmaceuticals Inc. reports significant business developments post-FY 2025, including the launch of immunotherapy LYMPHIR for CTCL patients and upcoming market strategies.

Citius Pharmaceuticals Unveils 2025 Financial Results and Strategic 2026 Goals #USA #CTXR #Cranford #LYMPHIR #Citius_Oncology

Citius Oncology's 2025 Financial Results Highlight Major Milestones and LYMPHIR Rollout Citius Oncology, Inc. shares its significant achievements from FY 2025, including the launch of LYMPHIR and substantial financial updates, marking a transformative year.

Citius Oncology's 2025 Financial Results Highlight Major Milestones and LYMPHIR Rollout #United_States #Cranford #Cancer_Treatment #LYMPHIR #Citius_Oncology

Dre Garcia’s pick, handoff to Greg Brown, earns Ridge Red Devils the win for the 2025 Highlight Reel Play of the Year Seven nominees, seven really good highlights. But in the end, the fans must pick one. With nearly six thousand votes cast, the Ridge Red Devils nearly had a plurality, earning almost 29-hundred votes - and almost 48 percent of the total - in our fan balloting for the 2025 Highlight Reel Play of the Year. And like many nominees - and some past champions - it wasn't a play that was drawn up or routinely worked on at the end of practice.

WINNER in FAN VOTE! Dre #Garcia's pick, handoff to Greg #Brown, earns #Ridge #RedDevils the win for the 2025 #HighlightReel #PlayoftheYear! Plus HMs from #BoundBrook and #Cranford! #NJFootball #BigCentral

Citius Oncology Secures $18 Million in Direct Offering and Private Placement for Future Growth Citius Oncology successfully closes an $18 million capital raise through a direct offering and private placement aimed at accelerating commercialization of LYMPHIR.

Citius Oncology Secures $18 Million in Direct Offering and Private Placement for Future Growth #USA #Cranford #LYMPHIR #Citius_Oncology #Nasdaq_CTOR

Citius Oncology Secures $18 Million for Innovative Cancer Immunotherapy Launch Citius Oncology, a subsidiary of Citius Pharmaceuticals, announces an $18 million simultaneous registered direct offering and private placement to boost the launch of its cancer treatment, LYMPHIR.

Citius Oncology Secures $18 Million for Innovative Cancer Immunotherapy Launch #United_States #Cranford #LYMPHIR #Citius_Oncology #Nasdaq_CTOR

It’s time for you – the fans – to pick the Central Jersey Sports Radio 2025 “Highlight Reel Play of the Year!” Watch, then vote! Central Jersey Sports Radio is giving YOU the chance to weigh in on your favorite play of the 2025 high school football season, as submitted by Big Central Conference coaches! All our finalists are in the montage below... Watch the video below, then scroll down to vote for your favorite!!Voting ends at NOON on Monday, 8th. Remember: Vote early, vote often! The winner will be announced during our Big Central Conference Postseason Awards Show on Thursday, December 11 at 7 pm!

It's time for you - the fans - to pick the Central Jersey Sports Radio 2025 "Highlight Reel Play of the Year!" Watch, then vote! #BoundBrook #Cranford #Johnson #Metuchen #Montgomery #Ridge #Woodbridge! #BigCentral #NJFootball

Citius Oncology Partners with Er-Kim to Broaden LYMPHIR Distribution in Turkey and the Middle East Citius Oncology has signed an exclusive agreement with Er-Kim to distribute its novel cancer therapy LYMPHIR in Turkey and GCC countries, enhancing patient access.

Citius Oncology Partners with Er-Kim to Broaden LYMPHIR Distribution in Turkey and the Middle East #Cranford #Turkey #LYMPHIR #Citius_Oncology #Er-Kim

Citius Oncology Launches LYMPHIR™ to Transform CTCL Treatment Landscape Citius Oncology has launched LYMPHIR™, an innovative immunotherapy for treating relapsed cutaneous T-cell lymphoma. This breakthrough offers hope to many patients.

Citius Oncology Launches LYMPHIR™ to Transform CTCL Treatment Landscape #United_States #Cranford #LYMPHIR #Citius_Oncology #Cutaneous_T-Cell_Lymphoma

Citius Oncology Partners with Verix for Enhanced LYMPHIR™ Launch Targeting With AI Citius Oncology is set to enhance the commercial launch of LYMPHIR™ by integrating AI technology from Verix, optimizing engagement with healthcare providers.

Citius Oncology Partners with Verix for Enhanced LYMPHIR™ Launch Targeting With AI #USA #Cranford #LYMPHIR #Citius_Oncology #Verix_AI

Asterism.org – Home of Amateur Astronomers, Inc.

Astronomy Club - North Jersey

We are members of our local astronomy club:

asterism.org

Small, but a lot of fun. And they also bring around guest lecturers (including folks from NASA)

Membership is reasonable too…

#Astronomy
#AstronomyClubs
#Space
#NightSky
#NewJersey
#Cranford

My old work apt was in cranford nj. They had the best Halloween contest. Here is a fav entry from years ago. #halloween #cranford #nj

The playoffs are here! Part Two of our first round, Big Central postseason preview, with a look at Groups 1 through 3 It's time for the playoffs! We got through opening weekend in the sweltering heat of the late dog days of August. We didn't really have much of a fall, but the weather mostly nice. And Cutoff Weekend last weekend saw some teams sweating it out, some disappointed, and others rewarded for their play during the season. Now, it's time to get it all going!

The #playoffs are here! Part Two of our first round, #BigCentral postseason #preview, with a look at Groups 1 through 3! Including #Cranford #Summit #Somerville #Bernards #Voorhees #Johnson #Brearley #NewProvidence #BoundBrook and #Manville! #NJFootball #NJSIAA

Cutoff Weekend Friday Playoff Update – Group 3: Summit stands pat, Somerville up, but neither can gain top-seed; South Plainfield looks out With Friday night's Cutoff Weekend high school football games all in the books, Central Jersey Sports Radio is updating the unofficial NJSIAA playoff standings as we head into Saturday action. We'll have further analysis late morning into the afternoon Saturday, with our 2025 "Playoff Projection Show" scheduled for 6 pm where we give our bracket projections. The full tournament for the public schools will be unveiled on Sunday by the NJSIAA via Gridiron New Jersey.

#CutoffWeekend Friday #Playoff Update - Group 3: #Summit stands pat, #Somerville up, but neither can gain top-seed; #South Plainfield looks out. Plus #Cranford! #NJFootball #BigCentral #NJSIAA

Citius Pharmaceuticals Completes $6 Million Direct Offering to Fuel Growth Citius Pharmaceuticals has successfully finalized a direct offering worth $6 million. The proceeds will propel the launch of its innovative product, LYMPHIR, and further its development initiatives.

Citius Pharmaceuticals Completes $6 Million Direct Offering to Fuel Growth #United_States #Cranford #Citius_Pharmaceuticals #LYMPHIR #Nasdaq_CTXR

Citius Pharmaceuticals Initiates $6 Million Direct Share Offering Under Nasdaq Regulations Citius Pharmaceuticals announces a registered direct offering worth $6 million under Nasdaq regulations, aimed at supporting product development.

Citius Pharmaceuticals Initiates $6 Million Direct Share Offering Under Nasdaq Regulations #United_States #Cranford #Citius_Pharmaceuticals #Clinical_Trials #LYMPHIR

Citius Oncology Partners with McKesson for LYMPHIR™ Distribution to Enhance Patient Access Citius Oncology has entered into a distribution agreement with McKesson Corporation, enhancing access to LYMPHIR™, an innovative immunotherapy for CTCL patients.

Citius Oncology Partners with McKesson for LYMPHIR™ Distribution to Enhance Patient Access #United_States #Cranford #LYMPHIR #Citius_Oncology #McKesson

Citius Oncology Partners with EVERSANA to Launch LYMPHIR™ in 2025 Citius Oncology announces an exclusive partnership with EVERSANA for the U.S. launch of LYMPHIR™, a breakthrough treatment for CTCL, set for late 2025.

Citius Oncology Partners with EVERSANA to Launch LYMPHIR™ in 2025 #United_States #Cranford #EVERSANA #LYMPHIR #Citius_Oncology

Group 3 Playoff Chase for Week 7: Summit, Somerville look up at top seeds; do they have a shot at getting one? Can South Plainfield and Carteret make it? With the NJSIAA's Cutoff Weekend for high school football next week in New Jersey, Central Jersey Sports Radio is taking a closer look at the race for the playoffs, including who's in the running for top seeds, who's in, who's jockeying for position, and who has some work to do just to get in, or stay in the hunt. We'll break down each supersection, with individual team analysis for all Big Central Conference schools.

Group 3 #Playoff Chase for Week 7: #Summit, #Somerville look up at top seeds; do they have a shot at getting one? Can #SouthPlainfield and #Carteret make it? Plus #Cranford looks like they're in. #NJFootball #BigCentral #NJSIAA

NJ teen motorist in deadly hit-and-run could be charged as an adult — after juvenile charges spark outrage Vinnie Battiloro has been charged as a juvenile with two counts of first-degree murder.

My pal @drjwilliams.bsky.social (Justice Studies) is quoted in this #NewYorkPost article about the 17-year-old accused of a deadly hit-and-run in #Cranford. nypost.com/2025/10/04/u...